Changming Zhai

Changming Zhai


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CMChongyang Ma
Chongyang Ma
FCFafeng Cheng
Fafeng Cheng
XWXueqian Wang
Xueqian Wang
CZChangming Zhai
Changming Zhai
WYWenchao Yue
Wenchao Yue
QWQingguo Wang
Qingguo Wang
During the past decade, accumulating evidence from both clinical and experimental studies has indicated that erythropoietin may have antidepressant effects. In addition to the kidney and liver, many organs have been identified as secretory tissues for erythropoietin, including the brain. Its receptor is expressed in cerebral and spinal cord neurons, the hypothalamus, hippocampus, neocortex, dorsal root ganglia, nerve axons, and Schwann cells. These findings may highlight new functions for erythropoietin, which was originally considered to play a crucial role in the progress of erythroid differentiation. Erythropoietin and its receptor signaling through JAK2 activate multiple downstream signaling pathways including STAT5, PI3K/Akt, NF-κB, and MAPK. These factors may play an important role in inflammation and neuroprogression in the nervous system. This is particularly true for the hippocampus, which is possibly related to learning, memory, neurocognitive deficits and mood alterations. Thus, the influence of erythropoietin on the downstream pathways known to be involved in the treatment of depression makes the erythropoietin-related pathway an attractive target for the development of new therapeutic approaches. Focusing on erythropoietin may help us understand the pathogenic mechanisms of depression and the molecular basis of its treatment.

7 April 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
FCFafeng Cheng
Fafeng Cheng
CMChongyang Ma
Chongyang Ma
XWXueqian Wang
Xueqian Wang
CZChangming Zhai
Changming Zhai
GWGuoli Wang
Guoli Wang
CCcongai cong chen
congai cong chen
Nonalcoholic fatty liver disease (NAFLD) represents one of the most common forms of liver disease worldwide, and it is always regarded as a consequence of a sedentary, food-abundant lifestyle, sitting for an extended time, and a low physical activity level, which often coincide with chronic and long-lasting psychological stress. A Chinese medicine Sinisan (SNS) may be a potential formula for treating this kind of disease. In this study, a long-term chronic restraint stress protocol was used to investigate the mechanism underlying stress-induced NALFD. To investigate the effect of SNS treatment on stress-induced NAFLD, we measured the liver and serum values of total cholesterol (TC), triglyceride (TG), liver free fatty acids (FFA), low-density lipoprotein, superoxide dismutase, tumor necrosis factor-α, malondialdehyde, interleukin (IL)-6, and serum values of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase. Results are shown as a mean ± standard deviation. Significant differences between the groups were evaluated using the Student t-test. For multiple comparisons, one-way analysis of variance (ANOVA) was used. If the results of ANOVA indicated significant differences, post hoc analysis was performed with the Tukey test or Dunnett test, and p < 0.05 was considered statistically significant. Long-term chronic stress led to steatosis and non-alcoholic steatohepatitis. Additionally, SNS treatment significantly increased body weight gain (p < 0.01) and sucrose preference (p < 0.001), and it reduced the liver values of TC, TG, and FFA (p < 0.05). SNS also reduced the serum values of AST and ALT (p < 0.001), and the liver value of IL-6 (p < 0.01). This study’s results demonstrate that psychological stress may be a significant risk factor of NAFLD. Furthermore, the traditional Chinese medicine formula SNS may have some beneficial effect in antagonizing psychological stress and stress-related NAFLD.

24 October 2025 in Medicine
Verified
Journal Article
Open access
JLJiaoyue Li
Jiaoyue Li
FLFawei Li
Fawei Li
SZSijia Zhang
Sijia Zhang
CZChangming Zhai
Changming Zhai
XMXiaona Ma
Xiaona Ma
This study aims to identify angiogenesis-associated genes (AAGs) in endometriosis (EM) by integrating bioinformatics analysis with machine learning, and to investigate their underlying mechanisms. Differentially expressed genes (DEGs) were screened from integrated EM-related gene sets in the Gene Expression Omnibus database. These DEGs were integrated with AAGs retrieved from the AMIGO2 database. Weighted gene co-expression network analysis (WGCNA) was then employed to identify potential EM-AAGs, followed by functional enrichment analysis using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes. Five machine learning algorithms – Random Forest, LASSO, XGBoost, Gradient Boosting Machine (GBM), and SVM-RFE – were utilized for cross-validated screening of hub genes. The diagnostic efficacy of these genes was evaluated through receiver operating characteristic curves, calibration curves, and decision curve analysis. Further analyses included single-gene gene set enrichment analysis (GSEA), immune infiltration profiling, prediction of regulatory transcription factors, and construction of a competitive endogenous RNA (ceRNA) network. This study identified FZD4, SRPX2, and COL8A1 as hub genes for angiogenesis in EM. These genes were significantly upregulated in EM patients and demonstrated excellent diagnostic efficacy. Immune infiltration analysis revealed their regulatory associations with immune cell subpopulations, including M1/M2 macrophages and neutrophils. Single-gene GSEA and competitive endogenous RNA (ceRNA) network construction further elucidated their core regulatory roles in cell cycle control and multi-tiered molecular networks. Integrated bioinformatics and machine learning revealed FZD4, SRPX2, and COL8A1 as hub genes of angiogenesis in EM, proposing novel anti-angiogenic therapeutic strategies targeting EM.